Suggestions
Paul Kohlhaas
CEO and blockchain innovator
Paul Kohlhaas is a prominent entrepreneur and innovator in the blockchain and biotechnology space. He is currently the Core Lead and Founding Member at bio.xyz.1 Some key points about Paul Kohlhaas:
Professional Experience
- Co-Founder & CEO of Molecule AG since January 20184
- Founding Steward of VitaDAO since May 20214
- Previously held positions such as:
- Vice Chairman at Advanced Blockchain AG
- Director of Business Development at ConsenSys
- Founder & CEO of Linum Labs4
Background and Education
- Studied Economics & International Affairs at the University of St.Gallen
- Took courses in Bitcoin and Cryptocurrency Technologies at Princeton University
- Completed an exchange semester at the University of Cape Town, studying International Trade, Finance, Microeconomics, and Comparative Politics
Current Focus
Paul is known for his work in decentralized science (DeSci) and biotechnology. At bio.xyz, he is working to revolutionize the way scientific research is funded and conducted.2 His vision involves:
- Creating decentralized autonomous organizations (DAOs) for biotech research
- Connecting scientists, patients, and investors directly
- Addressing funding gaps in drug development
- Promoting transparency and open innovation in biotechnology3
Paul Kohlhaas is recognized as a visionary in the field, aiming to bring biotechnology "back into the hands of the people" through decentralized, open-source methods.3
Highlights
Excited to be in San Francisco for JPM Healthcare next week! If you‘re in town and want to learn about #DeSci decenentralised science, Biotech DAOs or tokenized intellectual property in biopharma hit me up to meet 1-1
It's my first time at JPM and I hear the crowd and network is electrifying - excited to share how Molecule AG VitaDAO might alter the pharma funding and drug discovery landscape
We're also hosting a meetup with Michael Baran Pfizer on Wednesday at the infamous Fifty Years office together with our friends at Atria VC Chris Leiter
Sign up 👇 https://lu.ma/01eg8x8i
I rarely post on LinkedIn, but when I do, it's great news.
I'm humbled and in awe to announce that Molecule just closed a $12.7m funding round with +60 investors spanning biotech and web3 led by Northpond Ventures and Shine Capital 1kx KdT Ventures Fifty Years Breyer Capital Speedinvest Cherry Ventures L1 Digital AG Petri Bio Pillar VC Inflection VC Amino Collective Balajis Srinivasan Chris Leiter Steve Wiggins Zen Chu and so many more.
Molecule's mission is to create public infrastructure that enables decentralized, democratic and open medicine development for humanity. To achieve this we're providing researchers with a novel intellectual property framework. And patients w/ new organizational tools to govern IP.
Many of the investors/DAOs are too niche for LinkedIn profiles so rather than naming them all I'm just going to Link to our announcement.
If you're excited about the forefront of decentralized science, or #desci hit me up!
